Neurosense Therapeutics Ltd (NRSNW) SEC News Sept. 02, 2025, 12:36 UTC New Form 6-K - NeuroSense Therapeutics Ltd. Filed: 2025-09-02 AccNo: 0001213900-25-082945 Size: 13 KB Full text
There are no comments here yet...